AVITA Medical outlines $3.5B US market opportunity with expanded product portfolio and 2025 revenue guidance

Stock Information for Avita Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avita Medical Inc.

Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
AVITA Medical to Present at the Piper Sandler 37?? Annual Healthcare Conference
Bragar Eagel & Squire, P.C. Encourages Agilon, Soleno, Avita, and Coty Investors to Contact the Firm Regarding Ongoing Investigations
Bragar Eagel & Squire, P.C. Is Investigating Agilon, Soleno, Avita, and Coty and Encourages Investors to Contact the Firm
AVITA Medical to Host Investor Webinar Briefing
AVITA® Medical Reports Third Quarter 2025 Financial Results
Data Presented at the 2025 Southern Region Burn Conference Reinforce RECELL® System as a Standard of Care in Acute Wound Treatment
AVITA Medical to Announce Third Quarter 2025 Financial Results

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.